Position in TMO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$909,011,300
-$82,040,973 QoQ
Shares Held
1,813,091
-10.1% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#38
of 2,617 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Amundi holds $3,308,384,187 across 24 Diagnostics & Research names. TMO ranks #1 (27.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
1,813,091 | $909,011,300 | |
| 2 | DHR |
Danaher Corp /De/
|
2,883,536 | $549,255,932 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
240,640 | $307,420,004 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
569,725 | $299,926,027 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
957,792 | $185,064,568 | |
| 6 | WAT |
Waters Corp /De/
|
464,501 | $174,206,454 | |
| 7 | A |
Agilent Technologies, Inc.
|
1,294,098 | $171,895,036 | |
| 8 | LH |
Labcorp Holdings Inc.
|
596,662 | $167,065,360 |
All Filings in TMO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $909,011,300 | 1,813,091 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $991,052,273 | 2,016,260 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $954,366,895 | 1,647,022 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $769,727,222 | 1,587,001 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $964,672,860 | 2,379,206 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,507,252,286 | 3,029,044 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,488,298,421 | 2,860,847 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $1,559,157,629 | 2,520,584 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,312,873,429 | 2,374,093 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,281,264,648 | 2,204,478 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,322,832,174 | 2,492,195 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,469,071,861 | 2,902,329 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,482,756,620 | 2,841,891 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,623,584,710 | 2,816,914 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,723,817,185 | 3,130,286 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,507,867,236 | 2,972,983 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,009,717,378 | 1,858,558 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $1,149,015,646 | 1,945,341 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,304,825,841 | 1,955,557 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,193,409,527 | 2,088,827 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $893,779,069 | 1,771,719 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||